Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DANR, buys coming in now after some profit taking
RTK looks like good entry. Noticed an insider sold quite a few shares a couple weeks ago, anyone no anthing about this or why he may have sold?
Oh yeah, much uglier. I await JD next bonehead move to take her down to trip zero's then it should be fun to play again.
MRNA nice buying EOD with HOD close. It's day is coming.
"JD was very candid. I like that. Tell it all, as it is, instead of leaving shareholders wondering or misleading them. He said he believes in telling the truth. Now if all pink CEOs would think that way..."[
This is laughable, shareholders haven't at all been "wondering" what the hell is going on the past 3 month, lol
MRNA uting, going to break out big one of these days, IMO
DANR I was sitting a little lower on the bid. Sad to see that dump on that news. Not gonna chase.
DANR dumpathon on news.
Read my last post, I don't hold these POS. A bounce opp presented itself late last friday IMO. Don't worry about me bud.
In EOD Friday, out this morning. Small profit, thought it might bounce a little harder and it still may but not taking the chance.
This picture of you makes so much sense now!! Stick to weight lifting and searching for you shriveled up nuts meat head!! LMFAO
There is no delay in Q3. He has them, he just chooses to be a scumbag and not release them like he said he would. There probably horrible if I was to guess. For whatever reason, JD has turned into a silent, ungrateful, pos, pink ceo. When a relatively transparent CEO turns and becomes totally untransparent and silent it's never good. If I was to guess, he's in some trouble legally for some of his previous acions.
"Just called T/A and the dilution continues,however now selling on the way up. O/S today is 304,285,367 not sure what yesterday was but an increase of 57 million from Feb. 24th"
Explain to me how the OS can increase 57 mil in 2 days when there were only about 18 mil traded in those 2 days??
Regardless, I know nothing about the this POS company but the charts telling me that theres been no new shares added the past couple days. Chart indicators screaming bounce here, we shall see. IMO
joined the party here with you xbig. Chart is starting to look explosive.
Gold, what you think of C here in the mid 3.30's?
So my take on it is correct?
Hey, i don't know if you seen the news here this a.m. but was wondering if you might have a better grip of what this means for any shareholders if and when this buyout takes place.
My take is if this buyout takes place, it is going to be taken private. Does this mean if you are a shareholder at the time of the buyout you will be paid .34 a share??
PINN Pinnacle Gas Resources, Inc. Enters Into Agreement to be Acquired By Investor Group
SHERIDAN, Wyo., Feb. 24 /PRNewswire-FirstCall/ --
Pinnacle Gas Resources, Inc. (NASDAQ:PINN) announced today that it has entered into a definitive agreement pursuant to which an investor group will acquire Pinnacle in an all cash transaction for $0.34 per share of common stock, representing a premium of approximately 28% to Pinnacle's closing share price of $0.265 on February 23, 2010. The investor group is led by Scotia Waterous (USA) Inc. and includes certain members of Pinnacle's management team. Upon consummation of the merger, the common stock of Pinnacle will no longer be publicly owned or publicly traded.
The Agreement and Plan of Merger was unanimously approved by Pinnacle's Board of Directors, upon the unanimous recommendation of a Special Committee of the Board, which was comprised solely of independent directors. The Board has recommended that Pinnacle shareholders vote in favor of the merger agreement.
The Special Committee was formed in October 2009 to review proposals regarding asset divestitures, strategic transactions, capital restructuring (including additional or new debt or equity financing), and other alternatives to address the Company's liquidity constraints arising out of the recent economic and natural gas pricing environment.
"The Special Committee considered a range of potential alternatives, including continuing to operate as an independent entity, possible sales of certain assets, the Company's ability to issue additional equity in a public or private offering, and restructurings of the Company's outstanding debt," said Tom McGonagle, Chairman of the Board and member of the Special Committee. "After conducting an exhaustive evaluation of the alternatives, the Special Committee and Pinnacle's Board of Directors unanimously concluded that this transaction with Scotia Waterous leading the investor group is in the best interests of our shareholders."
The transaction is subject to the approval of Pinnacle's shareholders (including the approval of a majority of the shareholders of Pinnacle who are unaffiliated with DLJ Merchant Banking Partners III, L.P. or the Company's Chief Executive Officer or Chief Financial Officer), customary closing conditions and, unless waived by the investor group, certain acceptable amendments to its credit facility. The merger is expected to close during the second quarter of 2010.
In connection with the transaction, FBR Capital Markets & Co. acted as financial advisor to the Special Committee, and Scotia Waterous acted as financial advisor to the investor group.
About Pinnacle
Pinnacle Gas Resources, Inc. is an independent energy company engaged in the acquisition, exploration and development of domestic onshore natural gas reserves. It focuses on the development of coalbed methane (CBM) properties located in the Rocky Mountain region. Pinnacle holds CBM acreage in the Powder River Basin in northeastern Wyoming and southern Montana as well as in the Green River Basin in southern Wyoming. Pinnacle Gas Resources was founded in 2003 and is headquartered in Sheridan, Wyoming.
About Scotia Waterous (USA) Inc.
Scotia Waterous is the oil and gas investment and merchant banking division of The Bank of Nova Scotia with offices in Beijing, Buenos Aires, Calgary, Denver, Houston, London and Singapore. Scotia Waterous is currently in the process of raising an emerging manager fund and has three existing private oil and gas portfolio companies. Scotia Waterous is distinguished by its in-depth knowledge of the oil and gas sector and comprehensive technical understanding of oil and gas assets on a worldwide basis.
Additional Information and Where to Find It
The proposed merger will be submitted to Pinnacle's shareholders for their consideration, and Pinnacle will file a proxy statement to be used to solicit shareholder approval of the proposed merger, as well as other relevant documents concerning the proposed transaction with the Securities and Exchange Commission (the "SEC"). Pinnacle shareholders are urged to read the proxy statement regarding the proposed transaction when it becomes available and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information. Shareholders will be able to obtain a free copy of the proxy statement, as well as other filings with the SEC containing information about Pinnacle, at the SEC's website at http://www.sec.gov/. Copies of the proxy statement can also be obtained, when available, without charge, by directing a request to Pinnacle Gas Resources, Inc., Investor Relations, 1 East Alger, Sheridan, Wyoming, 82801 or at Pinnacle's corporate website at http://www.pinnaclegas.com/.
Participant Information
Pinnacle and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Pinnacle shareholders in connection with the proposed merger. Certain information regarding the participants and their interests in the solicitation is set forth in the Form 10-K filed by Pinnacle with the SEC on April 15, 2009 and Form 10-K/A filed by Pinnacle with the SEC on December 1, 2009 which are available free of charge from the SEC and Pinnacle at their websites as indicated above. Information regarding the interests of these persons in the solicitation will be more specifically set forth in the proxy statement concerning the proposed merger that will be filed by Pinnacle with the SEC and which will be available free of charge from the SEC and Pinnacle, as indicated above.
Safe Harbor
This press release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933 (the "Securities Act") and the Securities Exchange Act of 1934 (the "Exchange Act"). All statements other than statements of historical facts included in this news release regarding the proposed merger, including the timing thereof, the likelihood that such transaction could be consummated and other statements that are not historical facts, including any relating to Pinnacle's financial position, business strategy, plans and objectives of management for future operations, industry conditions, and indebtedness covenant compliance are forward-looking statements. When used in this report, forward-looking statements are generally accompanied by terms or phrases such as "estimate," "project," "predict," "believe," "expect," "anticipate," "target," "plan," "intend," "seek," "goal," "will," "should," "could," "may" or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about, actual or potential future sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements.
Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, general economic or industry conditions, nationally and/or in the areas in which we conduct our business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting our operations, products, services and prices.
Company contact: Attention: Investor Relations, (307) 673-9710
DATASOURCE: Pinnacle Gas Resources, Inc.
CONTACT: Ronald Barnes, Chief Financial Officer, Pinnacle Gas Resources,
Inc., +1-307-673-9710
Web Site: http://www.pinnaclegas.com
MRNA AllAllan.blogspot.com just did a GREAT write up !!!
MRNA
This story begins back in the fall of 2006, when Merck paid $1.1B for Sirna Therapeutics, a little RNA interference technology, a/k/a RNAi, In 2001, Merck bought another biotech, Rosetta Inpharmatics, which specializes in this "targeted" type of RNAi technology.
We've had some success in prior blogs isolating and speculating on RNAi stocks. Let's dip our toes back in again with MRNA. Here is my executive summary (read: quick and capsuled analysis):
(1) Both MRNA's CEO and Chief Scientific Officer are from Sirna, so not just one guy, but two guys, in a real sense, the two most important guys;
(2) The company is focused on Liver and Bladder cancer, two areas without much effective treatment as best I can tell, again, this bodes well for their business model;
(3) Existing licensing agreements with Hoffman-LaRoche and Novartis;
(4) Something happened in early 2010 causing them to bring bladder cancer to the forefront and say that an IND would be filed THIS YEAR, by the fourth quarter;
(5) At same time, they upped forecast from one to two deals with big pharma by year end.
All of this is good, very, very, good, but so what? Lots of $100-300 million dollar market cap companies have characteristics like these, well, not lots, but some do. Except for this fact: MRNA current market cap is only $39M. THIRTY-NINE MILLION!
So my take on MRNA just going this far is that they should be valued at between 3X and 8X current market valuation. Sirna, which arguably had less going for it in 2006 then MRNA does now, was bought out by Merck for $1.1B in cash. What was that all about?
From the press at the time of Sirna's buy out:
"So why exactly did Merck buy Sirna? Because the biotech specializes in RNA interference technology, also known as RNAi, which could conceivably be used to control gene activity to destroy cancer cells without harming healthy cells. In 2001, Merck bought another biotech, Rosetta Inpharmatics, which specializes in this "targeted" type of RNAi technology.
"Sirna has no products on the market. The most advanced experimental product in the biotech's pipeline, a potential treatment for a type of eye disease that can cause blindness, is years away from market approval, assuming its tests are successful. But that experimental product, called Sirna-072, is not the big draw for Merck, according to Ding Ding, analyst for Maxim Group.
"I think Merck paid $1.1 billion in cash really to buy the technology platform," said Ding. "I'm not convinced that Merck is going to continue the current pipeline that Sirna has. The key pipeline that interests Merck is oncology."
Source: http://money.cnn.com/2006/10/31/news/companies/merck/index.htm
Admittedly, things are different now then they were in October, 2006. But only in macroeconomic matters, not so different in the pharmaceutical industry and its biotechnology incubators. Not that I think someone is going to pay $1.1B for MRNA (all though they might), but based on all of the above, the management, the platforms, the progress, the targeted diseases, I think the upper range of $100-$300M is more likely then the lower range and that the lower range is almost a lock. That's a lot of appreciation potential a year or two ahead.
MRNA, I bet news out tommorrow on it
MRNA 1.04 HOD ask getting slammed now
MRNA 1.02 x 1.03, about to break out. Psar dropped and breaking the 100ma here on nice volume
MRNA 1.02 x 1.03, about to break out. Psar dropped and breaking the 100ma here on nice volume
MRNA 1.01 x 1.02, nice volume. This ones overdue, chart looks great. MACD crossing over
MRNA 1.00 x 1.01 uting easily this morning
MRNA .99 x 1.00 uting easily this morning
MRNA, $1.00 break and run coming IMO
MRNA, nice breakout chart forming.
MRNA,$1.61?? that a target price??
MRNA, close over a buck would be sweet
C, 3.45 looks interesting here
Added MRNA again, huge break today of 20 and 50 ma's. Looking like the early stages of a nice uptrend.
MRNA, uting .95 x .955
MRNA, nice buying all day.
I'm not following, how does this free up tradeable shares?
MRNA, yep appears that way. Glad I grabbed some .875's. I personally believe this has been shorted for awhile. Awaiting a huge cover.
added MRNA, pressure building, she'll pop one of these days. Could see some major news anytime IMO
OS or AS???
Thanks